Alimera Sciences to Present at the Sidoti & Company Fall 2017 Conference
September 19 2017 - 9:25AM
Alimera Sciences, Inc. (Nasdaq:ALIM) (Alimera), a leader in the
commercialization and development of prescription ophthalmic
pharmaceuticals, today announced that Dan Myers, CEO, will present
at the Sidoti & Company Fall 2017 Conference at the New York
Marriott Marquis in New York, New York. Alimera Sciences’
presentation will take place Thursday, September 28th at 9:05AM
Eastern Time.
A live broadcast of the conference presentation will be
available. To access the broadcast, go to the "Investor Relations"
section of the Company's website at www.alimerasciences.com. A
replay of the conference presentation will also be available.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company
that specializes in the commercialization and development of
prescription ophthalmic pharmaceuticals. Alimera is presently
focused on diseases affecting the back of the eye, or retina,
because these diseases are not well treated with current therapies
and will affect millions of people in our aging populations.
Alimera’s commitment to retina specialists and their patients is
manifest in Alimera’s product and development portfolio designed to
treat early- and late-stage diseases. For more information, please
visit www.alimerasciences.com.
For press
inquiries: Katie Brazel for Alimera Sciences 404-317-8361
kbrazel@bellsouth.net |
For
investor inquiries:CG Capital for Alimera Sciences
877-889-1972 investorrelations@cg.capital |
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Sep 2023 to Sep 2024